Basic Information
ID: ALA4055655
Type: Functional
Description: In vivo inhibition of VAP-1 in STZ-induced diabetic Sprague-Dawley rat plasma at 0.3 to 1 mg/kg, po for 4 weeks measured after 24 hrs after final dose using 14C-benzylamine as substrate by scintillation spectrometric analysis
Format: BAO_0000218
Organism: Rattus norvegicus
Strain: Sprague-Dawley
Target: Rattus norvegicus(ALA376)
Document: ALA4052665
In vivo inhibition of VAP-1 in STZ-induced diabetic Sprague-Dawley rat plasma at 0.3 to 1 mg/kg, po for 4 weeks measured after 24 hrs after final dose using 14C-benzylamine as substrate by scintillation spectrometric analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4055655
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 567.91 | 2.74 | 2.74 |